Table 3.
Name | Format | Animal model | Target | Tissue/organ | References |
---|---|---|---|---|---|
E3A1 | scFv | CBA mice | Unknown | Thymus | Johns et al. (2000) |
K3.1 | scFv | Bourgogne brown rabbits | Carbonic anhydrase II | Atherosclerosis | Deramchia et al. (2012a); Deramchia et al. (2012b) |
P3 | scFv | Rabbit | Galectin-3 | Atherosclerosis | Hemadou et al. (2018); Hemadou et al. (2021) |
SCA A1 and SCA B1 |
scFv | Rats | Unknown | Pancreatic islets | Ueberberg et al. (2009); Ueberberg and Schneider (2010) |
269 | scFv | Cancer patients | Unknown | Tumor-targeting ligands | Krag et al. (2006) |
C-C7 | Llama nanobody | Mice | Dynactin-1-p150Glued | Glioma | van Lith et al. (2016) |
scFv 4 and scFv 40 | scFV | Rat | Unknown | BBB | Stutz et al. (2018) |
RG3 | sdAb | CD1 mice | Unknown | BBB | Aguiar et al. (2021) |
C5 | sdAb | Mice | Unknown | cNHL | Silva et al. (2021) |